Zions Bancorp N.A. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones11-30

DJ Zions Bancorp N.A. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Zions Bancorp N.A. $(ZION)$ slumped 0.26% to $60.52 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.56% to 6,032.38 and the Dow Jones Industrial Average rising 0.42% to 44,910.65.

This was the stock's third consecutive day of losses.

Zions Bancorp N.A. closed $2.70 short of its 52-week high ($63.22), which the company reached on November 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Wells Fargo & Co. $(WFC)$ fell 1.35% to $76.17, U.S. Bancorp $(USB)$ fell 0.36% to $53.29, and Citizens Financial Group Inc. (CFG) fell 0.04% to $48.14.

Trading volume (512,359) remained 837,351 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 29, 2024 17:34 ET (22:34 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment